Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis

Blood (2022) 140 (12): 1408–1418.

https://doi.org/10.1182/blood.2021015173

Published: 2022

Includes: Supplemental data

Journal Articles

Timing for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myelomonocytic Leukemia (CMML): A Joint Study from the International MDS/MPN Working Group and the Chronic Malignancies Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 4581.

https://doi.org/10.1182/blood-2019-125077

Published: 2019

Journal Articles

Safety, Tolerability and Activity of Ofatumumab, Bendamustine and Dexamethasone Combination As First-Line Treatment of Mantle-Cell Lymphoma in the Elderly: A Multicenter Study

Blood (2011) 118 (21): 1647.

https://doi.org/10.1182/blood.V118.21.1647.1647

Published: 2011

Journal Articles

Temsirolimus, An mTOR Inhibitor, In Combination with Low-Dose Clofarabine in Older Patients with Advanced Acute Myeloid Leukemia: Results of a Phase 2 GIMEMA Study (AML-1107)

Sergio Amadori, MD, Adriano Venditti, MD, Emanuele Ammatuna, MD, Alberto M. Martelli, MD, Giovanna Meloni, MD, Fabrizio Pane, MD, Giovanni Martinelli, MD, Monia Lunghi, Livio Pagano, MD, Daniela Cilloni, MD, PhD, Vittorio Rizzoli, Francesco Di Raimondo, MD, Claudio Fozza, MD, Luciana Annino, MD, Alfonso Piciocchi, Edoardo La Sala, Paola Fazi, MD, Marco Vignetti, MD

Blood (2010) 116 (21): 510.

https://doi.org/10.1182/blood.V116.21.510.510

Published: 2010

Journal Articles

The Immunomodulatory Drugs Lenalidomide and Pomalidomide Inhibit Multiple Myeloma-Induced Osteoclast Formation and RANKL/OPG Ratio In Myeloma Microenvironment Targeting the Expression of Adhesion Molecules

Marina Bolzoni, Manuela Abeltino, Paola Storti, PhD, Sabrina Bonomini, Luca Agnelli, Katia Todoerti, PhD, Antonino Neri, MD, Vittorio Rizzoli, MD, PhD, Nicola Giuliani, MD, PhD

Blood (2010) 116 (21): 448.

https://doi.org/10.1182/blood.V116.21.448.448

Published: 2010

Journal Articles

In Vitro and In Vivo Evidences of Osteocyte Involvement In Myeloma-Induced Osteolysis

Nicola Giuliani, MD, PhD, Paola Storti, PhD, Manuela Abeltino, Marina Bolzoni, Marzia Ferretti, Mirca Lazzaretti, PhD, Benedetta Dalla Palma, Katia Todoerti, PhD, Eugenia Martella, MD, Luca Agnelli, Antonino Neri, MD, Vittorio Rizzoli, MD, PhD, Carla Palumbo

Blood (2010) 116 (21): 131.

https://doi.org/10.1182/blood.V116.21.131.131

Published: 2010

Journal Articles

HOXB7 Is Critically Involved in Multiple Myeloma-Induced Angiogenic Switch.

Paola Storti, Gaetano Donofrio, Marina Bolzoni, Simona Colla, Irma Airoldi, Valentina Sgobba, Manuela Abeltino, Katia Todoerti, Luca Agnelli, Mirca Lazzaretti, Cristina Mancini, Sabrina Bonomini, Domenico Ribatti, Vito Pistoia, Antonino Neri, Vittorio Rizzoli, Nicola Giuliani

Blood (2009) 114 (22): 125.

https://doi.org/10.1182/blood.V114.22.125.125

Published: 2009

Journal Articles

Imatinib Mesylate Induced Cardiotoxicity: a Cardiac Progenitor Cell Disease?.

Lucia Prezioso, MD, Federica Galaverna, MD, Silvia Tanzi, Caterina Frati, Monia Savi, Costanza Lagrasta, Stefano Cavalli, Serena Galati, Francesca Ferraro, Antonella Deangelis, PhD, Elena Piegari, Francesco Rossi, Vittorio Rizzoli, Federico Quaini, MD

Blood (2009) 114 (22): 2200.

https://doi.org/10.1182/blood.V114.22.2200.2200

Published: 2009

Journal Articles

Arsenic Trioxide (ATO) Interacts Synergistically with MEK Inhibitors to Induce Apoptosis in STI571-Resistant Bcr-Abl Mutants.

Paolo Lunghi, Laura Mazzera, Attilio Corradi, Anna Maria Cantoni, Stefano Jottini, Guerino Lombardi, Micaela Ricca, Davide Arienti, Vittorio Rizzoli, Michael WN Deininger, MD, Antonio Bonati, MD

Blood (2009) 114 (22): 2177.

https://doi.org/10.1182/blood.V114.22.2177.2177

Published: 2009

Journal Articles

Diabetes Impairs Bone Marrow Microenvironment Affecting Progenitor Cell Number, Mobilization and Engraftment in Humans.

Vittorio Rizzoli, Elena Masselli, Lucia Prezioso, MD, Francesca Ferraro, Elisa Lodi-Rizzini, Marcellina Mangoni, Gallia Graiani, Caterina Frati, Gaia Spinetti, Carlotta Reni, Costanza Emanueli, Costanza Emanueli, Paolo Madeddu, Federico Quaini, MD

Blood (2009) 114 (22): 1482.

https://doi.org/10.1182/blood.V114.22.1482.1482

Published: 2009

Journal Articles

Pan-Aurora Kinase Inhibitor Mk-0457 Synergistically Potentiates Apo2L/Trail Cytotoxicity in Multiple Mieloma Cells Sensitive and Resistant to Bortezomib.

Paolo Lunghi, Laura Mazzera, Antonio Costanzo, Nicola Giuliani, Vittorio Rizzoli, Massimo Levrero, Antonio Bonati

Blood (2009) 114 (22): 1837.

https://doi.org/10.1182/blood.V114.22.1837.1837

Published: 2009

Journal Articles

Oxygen Tension in the Bone Marrow (BM) of Patients with Malignant and Indolent Monoclonal Gammopathy: Role of Hypoxia and Hypoxia-Inducible Factor (HIF)-1α in the Regulation of Gene Expression and Pro-Angiogenic Profiles of CD138 + Cells.

Nicola Giuliani, Simona Colla, Paola Storti, Valentina Sgobba, Katia Todoerti, Gaetano Donofrio, Marina Bolzoni, Manuela Abeltino, Mirca Lazzaretti, Sabrina Bonomini, Monica Crugnola, Antonino Neri, Vittorio Rizzoli

Blood (2009) 114 (22): 422.

https://doi.org/10.1182/blood.V114.22.422.422

Published: 2009

Journal Articles

Myeloma Cells Inhibit the Non-Canonical Wnt Co-Receptor Ror2 in Human Mesenchymal/Osteoprogenitor Cells: Effect of Wnt5a/Ror2 Pathway Activation On MM-Induced Impairment of the Osteogenic Differentiation Process.

Marina Bolzoni, Simona Colla, Paola Storti, Gaetano Donofrio, Manuela Abeltino, Valentina Sgobba, Sabrina Bonomini, Vittorio Rizzoli, Nicola Giuliani

Blood (2009) 114 (22): 741.

https://doi.org/10.1182/blood.V114.22.741.741

Published: 2009

Journal Articles

Increased Osteocyte Apoptosis in Multiple Myeloma Patients: A Potential Role in Bone Remodeling Alterations Related to Osteolytic Bone Lesions.

Nicola Giuliani, Marzia Ferretti, Manuela Abeltino, Cristina Mancini, Eugenia Martella, Benedetta Dalla Palma, Marina Bolzoni, Valentina Sgobba, Paola Storti, Vittorio Rizzoli, Carla Palumbo

Blood (2009) 114 (22): 830.

https://doi.org/10.1182/blood.V114.22.830.830

Published: 2009

Journal Articles

Are the Myeloma Bone Microevironment Cells Tumoral or Not?.

Nicola Giuliani, Francesca Novara, Katia Todoerti, Nadia Zaffaroni, Raffaella Villa, Paola Storti, Maria Ester Bernardo, Cristina Manferdini, Elena Gabusi, Manuela Abeltino, Marina Bolzoni, Luca Agnelli, Alberto Rocci, Simona Colla, Gabriella Sammarelli, Vittorio Rizzoli, Orsetta Zuffardi, Antonino Neri, Gina Lisignoli

Blood (2009) 114 (22): 1816.

https://doi.org/10.1182/blood.V114.22.1816.1816

Published: 2009

Journal Articles

Bone Microenvironment Cells Show a Different Pattern of Gene Expression Profiling in Relationship with the Presence of Osteolytic Bone Lesions in Multiple Myeloma Patients

Katia Todoerti, Gina Lisignoli, Simona Colla, Paola Storti, Luca Agnelli, Cristina Manferdini, Donata Verdelli, Monica Crugnola, Katia Codeluppi, Giorgio Lambertenghi Deliliers, Vittorio Rizzoli, Antonino Neri, Nicola Giuliani

Blood (2008) 112 (11): 2740.

https://doi.org/10.1182/blood.V112.11.2740.2740

Published: 2008

Journal Articles

Activation of Non-Canonical Wnt Pathway in Human Mesenchymal Cells Affects Osteogenic Differentiation: A Potential Target in Multiple Myeloma Microenvironment

Nicola Giuliani, Simona Colla, Paola Storti, Gaetano Donofrio, Marina Bolzoni, Sabrina Bonomini, Luisa Galla, Gabriella Sammarelli, Marcellina Mangoni, Vittorio Rizzoli

Blood (2008) 112 (11): 2742.

https://doi.org/10.1182/blood.V112.11.2742.2742

Published: 2008

Journal Articles

HOXB7 Overexpression in Mesenchymal Cells Stimulates the Production of Pro-Angiogenic Molecules: Potential Role in Multiple Myeloma Associated Angiogenesis

Simona Colla, Nicola Giuliani, Paola Storti, Mirca Lazzaretti, Katia Todoerti, Gina Lisignoli, Luca Agnelli, Cristina Manferdini, Sabrina Bonomini, Luisa Galla, Marina Bolzoni, Cristina Mancini, Gabriella Sammarelli, Marcellina Mangoni, Giorgio Lambertenghi Deliliers, Antonino Neri, Vittorio Rizzoli

Blood (2008) 112 (11): 2743.

https://doi.org/10.1182/blood.V112.11.2743.2743

Published: 2008

Journal Articles

Combined Treatment with the Mek Inhibitor PD0325901 and Arsenic Trioxide Has Potent Antitumor Activity in Vivo against Human Multiple Myeloma Xenograft Model.

Paolo Lunghi, Laura Mazzera, Guerino Lombardi, Micaela Ricca, Attilio Corradi, Anna Maria Cantoni, Nicola Giuliani, Luigi Salvatore, Roberta Riccioni, Antonio Costanzo, Ugo Testa, Massimo Levrero, Vittorio Rizzoli, Antonio Bonati

Blood (2008) 112 (11): 1712.

https://doi.org/10.1182/blood.V112.11.1712.1712

Published: 2008

Journal Articles

Phase II–III Study of Gemtuzumab Ozogamicin Monotherapy versus Best Supportive Care in Older Patients with Newly Diagnosed AML Unfit for Intensive Chemotherapy: First Results of the EORTC-GIMEMA AML-19 Trial

Sergio Amadori, Stefan Suciu, Dominik Selleslag, Giuliana Alimena, Liliana Baila, Vittorio Rizzoli, Giuseppe Rossi, Gianluca Gaidano, Domenico Magro, Giuseppe Torelli, Petra Muus, Adriano Venditti, Emma Cacciola, Francesco Lauria, Filip Beeldens, Marco Vignetti, Theo de Witte

Blood (2008) 112 (11): 762.

https://doi.org/10.1182/blood.V112.11.762.762

Published: 2008

NARROW

Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis

Timing for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myelomonocytic Leukemia (CMML): A Joint Study from the International MDS/MPN Working Group and the Chronic Malignancies Working Party of the EBMT

Safety, Tolerability and Activity of Ofatumumab, Bendamustine and Dexamethasone Combination As First-Line Treatment of Mantle-Cell Lymphoma in the Elderly: A Multicenter Study

Temsirolimus, An mTOR Inhibitor, In Combination with Low-Dose Clofarabine in Older Patients with Advanced Acute Myeloid Leukemia: Results of a Phase 2 GIMEMA Study (AML-1107)

The Immunomodulatory Drugs Lenalidomide and Pomalidomide Inhibit Multiple Myeloma-Induced Osteoclast Formation and RANKL/OPG Ratio In Myeloma Microenvironment Targeting the Expression of Adhesion Molecules

In Vitro and In Vivo Evidences of Osteocyte Involvement In Myeloma-Induced Osteolysis

HOXB7 Is Critically Involved in Multiple Myeloma-Induced Angiogenic Switch.

Imatinib Mesylate Induced Cardiotoxicity: a Cardiac Progenitor Cell Disease?.

Arsenic Trioxide (ATO) Interacts Synergistically with MEK Inhibitors to Induce Apoptosis in STI571-Resistant Bcr-Abl Mutants.

Diabetes Impairs Bone Marrow Microenvironment Affecting Progenitor Cell Number, Mobilization and Engraftment in Humans.

Pan-Aurora Kinase Inhibitor Mk-0457 Synergistically Potentiates Apo2L/Trail Cytotoxicity in Multiple Mieloma Cells Sensitive and Resistant to Bortezomib.

Oxygen Tension in the Bone Marrow (BM) of Patients with Malignant and Indolent Monoclonal Gammopathy: Role of Hypoxia and Hypoxia-Inducible Factor (HIF)-1α in the Regulation of Gene Expression and Pro-Angiogenic Profiles of CD138 + Cells.

Myeloma Cells Inhibit the Non-Canonical Wnt Co-Receptor Ror2 in Human Mesenchymal/Osteoprogenitor Cells: Effect of Wnt5a/Ror2 Pathway Activation On MM-Induced Impairment of the Osteogenic Differentiation Process.

Increased Osteocyte Apoptosis in Multiple Myeloma Patients: A Potential Role in Bone Remodeling Alterations Related to Osteolytic Bone Lesions.

Are the Myeloma Bone Microevironment Cells Tumoral or Not?.

Bone Microenvironment Cells Show a Different Pattern of Gene Expression Profiling in Relationship with the Presence of Osteolytic Bone Lesions in Multiple Myeloma Patients

Activation of Non-Canonical Wnt Pathway in Human Mesenchymal Cells Affects Osteogenic Differentiation: A Potential Target in Multiple Myeloma Microenvironment

HOXB7 Overexpression in Mesenchymal Cells Stimulates the Production of Pro-Angiogenic Molecules: Potential Role in Multiple Myeloma Associated Angiogenesis

Combined Treatment with the Mek Inhibitor PD0325901 and Arsenic Trioxide Has Potent Antitumor Activity in Vivo against Human Multiple Myeloma Xenograft Model.

Phase II–III Study of Gemtuzumab Ozogamicin Monotherapy versus Best Supportive Care in Older Patients with Newly Diagnosed AML Unfit for Intensive Chemotherapy: First Results of the EORTC-GIMEMA AML-19 Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only